DelMar Pharmaceuticals Receives Approval from China’s HGRAC to Initiate Phase 2 Clinical Trial
DelMar Pharmaceuticals , a biopharmaceutical company focused on the development of new cancer therapies announced that the HGRAC, has approved...
Samumed Receives Orphan Drug Designation from FDA for SM04646
Samumed announced that the U.S. FDA has granted SM04646, a novel small molecule Wnt pathway inhibitor, an Orphan Drug Designation...
Is 2017 set to be the year we see a CAR-T therapy approved? Let’s find out from the leaders in the field
Using your body’s own cells, engineering them to target tumors and cure cancer sounds like something from a Sci-Fi movie...
Lilly and Nektar Therapeutics Announce Alliance to Develop and Commercialize NKTR-358
Eli Lilly and Company and Nektar Therapeutics have announced a strategic collaboration to co-develop NKTR-358, a novel immunological therapy discovered...
Lexicon Collaborator Ipsen Receives Positive Chmp Opinion For Xermelo
Lexicon Pharmaceuticals, Inc. , announced that the Committee for Medicinal Products for Human Use (CHMP), the committee of the European...
AMO Pharma Enters into Development and License Agreement with Numedicus ltd
AMO Pharma Limited , a privately held biopharmaceutical company focusing on debilitating diseases with limited or no treatment options, announced...
PersonalMed Partners with Bergen’s Elevate Provider Network to Assist Compounding Pharmacies
PersonalMed, LLC, has entered into a collaborative agreement with AmerisourceBergen’s pharmacy services administrative organization (PSAO), Elevate Provider Network, to introduce...
Thermo Fisher Scientific Introduces Next Generation of Complementary Technologies for Forensic DNA Analysis
Forensic scientists who need to differentiate genetic profiles in forensic DNA mixtures, such as those commonly associated with crime scenes,...
DelMar Pharmaceuticals Receives IRB Approval for Pivotal Phase 3 Clinical Trial of VAL-083
DelMar Pharmaceuticals , a biopharmaceutical company focused on the development of new cancer therapies, announced it has received Institutional Review...
LEO Pharma appoints Chris Posner to lead US business
LEO Pharma announced that it appointed Chris Posner Executive Vice President Region US and President & CEO, LEO Pharma, Inc....
Latest News
About Us
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.